Use of TFF2, or agents inducing TFF2, in the therapy of allergies

Details for Australian Patent Application No. 2004206868 (hide)

Owner Children's Hospital Medical Center

Inventors Rothenberg, Marc Elliot

Agent Spruson & Ferguson

Pub. Number AU-A-2004206868

PCT Pub. Number WO2004/064860

Priority 60/440,934 17.01.03 US

Filing date 16 January 2004

Wipo publication date 5 August 2004

International Classifications

A61K 038/20 Medicinal preparations containing peptides - Interleukins

A61P 037/08 Drugs for immunological or allergic disorders

G01N 033/00 Investigating or analysing materials by specific methods not covered by groups

A61K 038/17 Medicinal preparations containing peptides - from animals

A61P 011/06 Drugs for disorders of the respiratory system

Event Publications

28 July 2005 PCT application entered the National Phase

  PCT publication WO2004/064860 Priority application(s): WO2004/064860

16 August 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004206869-Treatment of benign prostatic hyperplasia

2004206865-Bis (thio-hydrazide amide) compounds for treating multi-drug resistant cancer